✦ LIBER ✦

Compromised Fanconi anemia response due to BRCA1 deficiency in cisplatin-sensitive head and neck cancer cell lines

✍ Scribed by Kyunghee Burkitt; Mats Ljungman

Book ID: 116334405
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 378 KB
Volume: 253
Category: Article
ISSN: 0304-3835
DOI: 10.1016/j.canlet.2007.01.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phenylbutyrate interferes with the Fanco

Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin

✍ Kyunghee Burkitt; Mats Ljungman 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 801 KB

Variation in cisplatinum sensitivity is

Variation in cisplatinum sensitivity is not associated with Fanconi Anemia/BRCA pathway inactivation in head and neck squamous cell carcinoma cell lines

✍ Eric R. Snyder; Justin L. Ricker; Zhong Chen; Carter Van Waes 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Butyrate response factor 1 enhances cisp

Butyrate response factor 1 enhances cisplatin sensitivity in human head and neck squamous cell carcinoma cell lines

✍ Seung Koo Lee; Seong Bum Kim; Jong Soo Kim; Chang Hoon Moon; Myung Shin Han; Byu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 456 KB 👁 1 views

Cisplatin is a widely used chemotherapeutic agent in head and neck squamous cell carcinoma (HNSCC). Resistance to cisplatin is a common feature of HNSCC. To identify genes that may regulate cisplatin sensitivity, we carried out a cDNA microarray analysis of gene expression in cisplatin-sensitive and

Head and neck cancer cell lines exhibit

Head and neck cancer cell lines exhibit differential mitochondrial repair deficiency in response to 4NQO

✍ Michael M. Kim; Chad A. Glazer; Elizabeth Mambo; Aditi Chatterjee; Ming Zhao; Da 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Intrinsic differences in cisplatin sensi

Intrinsic differences in cisplatin sensitivity of head and neck cancer cell lines: Correlation to lysosomal pH

✍ Cathrine Nilsson; Karin Roberg; Roland C. Grafström; Karin Öllinger 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 390 KB 👁 2 views

## Abstract ## Background Cisplatin treatment is beneficial for approximately 20% of patients with head and neck squamous cell carcinoma (HNSCC). Tools to predict the clinical outcome and evaluate intrinsic cisplatin sensitivity are, therefore, required. ## Methods Cisplatin sensitivity, lysosom

The Roles of JNK1 and Stat3 in the Respo

The Roles of JNK1 and Stat3 in the Response of Head and Neck Cancer Cell Lines to Combined Treatment with All trans-retinoic Acid and 5-Fluorouracil

✍ Masuda, Muneyuki ;Toh, Satoshi ;Koike, Koji ;Kuratomi, Yuichiro ;Suzui, Masumi ; 📂 Article 📅 2002 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 682 KB